I/LA30

Immunoassay Interference by Endogenous Antibodies, 1st Edition

This guideline discusses the nature and causes of interfering antibodies, as well as their effects on immunoassays and mechanisms by which interference occurs. Methods to identify and characterize the interferences are addressed along with assessment of methods used to eliminate interference.

This document is available in electronic format only.

Member Price: as low as $42.00

Nonmember Price: $140.00
Log in to see your price and add to cart

Publication Details

Chairholder: Joan H. Howanitz, MD

Date of Publication: February 25, 2008

ISBN Number: 1-56238-658-1

Order Code PDF: ILA30AE

Order Code Print: print not available

Edition: First

Pages: 44

I/LA30 Additional Details

The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement.

This document is no longer being reviewed as part of our consensus process. However, because of its usefulness to a limited segment of the healthcare community, we are continuing to make the document available for its informational content.